Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Acarbose. Always confirm against the full prescribing information.
100 interactions
Abacavir
Acarbose may increase the hepatotoxic activities of Abacavir.
Level 2 evidence
Abiraterone
Acarbose may increase the hepatotoxic activities of Abiraterone.
Level 2 evidence
Acebutolol
The therapeutic efficacy of Acarbose can be increased when used in combination with Acebutolol.
Level 1 evidence
Acetaminophen
Acarbose may increase the hepatotoxic activities of Acetaminophen.
Level 2 evidence
Acetazolamide
Acarbose may increase the hepatotoxic activities of Acetazolamide.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Acarbose.
Level 1 evidence
Acitretin
Acarbose may increase the hepatotoxic activities of Acitretin.
Level 2 evidence
Albendazole
Acarbose may increase the hepatotoxic activities of Albendazole.
Level 2 evidence
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Acarbose.
Level 1 evidence
Allopurinol
Acarbose may increase the hepatotoxic activities of Allopurinol.
Level 2 evidence
Alogliptin
The risk or severity of hypoglycemia can be increased when Acarbose is combined with Alogliptin.
Level 2 evidence
Amcinonide
The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Acarbose.
Acarbose has 669 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Acarbose has 1 major, 380 moderate, and 288 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Acarbose. Always confirm against the full prescribing information.